Cited by 7Analytical Methods in PharmaceuticalsAnalytical Chemistry and ChromatographyCholinesterase and Neurodegenerative Diseases

Development and validation of high-performance liquid chromatography method for the simultaneous quantification of rivastigmine hydrogen tartrate and asiaticoside co-loaded in niosomes: A Box–Behnken design approach

Hnin, Hay Marn, Tun, Theingi, Jansook, Phatsawee·2024·Journal of Chromatography B

Abstract

Rivastigmine hydrogen tartrate (RHT), a reversible cholinesterase inhibitor, is considered as the first-line therapy for mild to moderate Alzheimer's disease. Asiaticoside (AS), a pentacyclic triterpenoid saponin, is well known as cognitive enhancer due to its antioxidant effect. Based on the hypothesis of their synergistic therapeutic potential, RHT and AS were co-encapsulated in niosomal formulation. A simple, precise, and accurate high-performance liquid chromatography method was developed for simultaneous quantitative analysis. The chromatographic parameters were optimized by Box-Behnken experimental design. The separation was performed on a reversed-phase Phenomenex C18 (150 mm × 4.6 mm, 5 μm) column at 30 °C under the UV detection of 210 nm. The optimized mobile phase consisted of a mixture of 20 mM potassium dihydrogen phosphate buffer (pH 2.6) and acetonitrile (72:28 % v/v) under the isocratic mode at the flow rate of 0.9 mL/min. The developed method was fully validated under the ICH guidelines and could be successfully applied for simultaneous quantitative analysis of RHT and AS in niosomal formulation.

Integrity signals

Registry

Crossref · 10.1016/j.jchromb.2024.124170

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hnin, H. M., Tun, T., & Jansook, P.
Affiliations
Chulalongkorn University (TH)
Corresponding author
Jansook, Phatsawee
Venue
Journal of Chromatography B
Publisher
Elsevier BV
Published
2024-07
Volume
1241
Pages
124170
ISSN
1570-0232 (ISSN-L)
OpenAlex
W4398238701
Cited by
7
References
31
Citations by year
2026: 2 · 2025: 4 · 2024: 1
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chromatography B (publishedVersion)
  • PubMed (publishedVersion)
Funders
Thailand Science Research and Innovation
Topics
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
  • Physical Sciences › Chemistry › Spectroscopy › Analytical Chemistry and Chromatography
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
asiaticoside, niosomes, simultaneous determination, HPLC method development, Box-Behnken design, drug co-loading, Alzheimer's disease, cholinesterase inhibitors, pentacyclic triterpenoid saponins, drug delivery formulation, method validation
MeSH terms
Rivastigmine, Chromatography, High Pressure Liquid, Liposomes, Triterpenes, Reproducibility of Results, Linear Models, Limit of Detection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review